×
About 534 results

Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
https://www.nejm.org/doi/full/10.1056/NEJMoa2007621
The New England Journal of Medicine;

Coronavirus disease 2019 (Covid-19) may disproportionately affect people with cardiovascular disease. Concern has been aroused regarding a potential harmful effect of angiotensin-converting–enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) in this clinical context.

Kaiser Permanente’s System Capabilities to Suppress Covid-19
https://catalyst.nejm.org/doi/full/10.1056/cat.20.0187
New England Journal of Medicine Catalyst;

Kaiser Permanente is developing eight capabilities aimed at suppressing the novel coronavirus that include robust testing, telehealth, contact tracing, partnerships with advocacy groups, planning for future surges, risk modeling to prioritize deferred care, and clinical research.

Coronavirus (Covid-19): New England Journal of Medicine Resource Center
https://www.nejm.org/coronavirus
New England Journal of Medicine;

A collection of articles and other resources on the Coronavirus (Covid-19) outbreak, including clinical reports, management guidelines, and commentary.

New Angiotensin Studies in COVID-19 Give More Reassurance
https://www.medscape.com/viewarticle/929992

May 4th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Four more studies of the relationship of angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) with COVID-19 have been published in the past few days in top-tier peer-reviewed journals, and on the whole, the data ...

COVID-19 Linked to Large Vessel Stroke in Young Adults
https://www.medscape.com/viewarticle/929345

Apr 23rd, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Physicians in New York City, which still leads the nation in reported COVID-19 cases, are reporting significantly more acute, large vessel strokes in young adults infected with COVID-19. In a rapid communication to be published onlin...

More Evidence Supports COVID-19/Guillain-Barré Link
https://emedicine.medscape.com/viewarticle/928975

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Five more cases of Guillain–Barré syndrome (GBS) in association with COVID-19 have been identified, further supporting a link between the virus and neurologic complications, including GBS. The account, from Italian researchers, comes a little more...

COVID-19 Daily: Early Remdesivir Data Published, World Leader Recovers
https://emedicine.medscape.com/viewarticle/928570

Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. Compassionate Use of Remdesivir More than two thirds of severely ill COVID-19 patients improved after being given the experimental drug remdesivir (Gilead Sciences, Inc), according to an analysis published in the New England Journal...

COVID-19 Daily: Early Remdesivir Data Published, World Leader Recovers
https://www.medscape.com/viewarticle/928570

Apr 11th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. Compassionate Use of Remdesivir More than two thirds of severely ill COVID-19 patients improved after being given the experimental drug remdesivir (Gilead Sciences, Inc), according to an analysis published in the New England Journal...

More Evidence Supports COVID-19/Guillain-Barré Link
https://www.medscape.com/viewarticle/928975

Apr 19th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Five more cases of Guillain–Barré syndrome (GBS) in association with COVID-19 have been identified, further supporting a link between the virus and neurologic complications, including GBS. The account, from Italian researchers, comes a little more...

Remdesivir Shortens COVID-19 Time to Recovery in Published Study
https://www.medscape.com/viewarticle/931064

May 22nd, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Much-anticipated results from the National Institute of Allergy and Infectious Diseases' clinical trial of remdesivir in COVID-19 patients published in the New England Journal of Medicine late Friday suggest remdesivir shorten...

HCQ Fails to Prevent COVID-19 in Randomized Trial
https://www.medscape.com/viewarticle/931703

Jun 2nd, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hydroxychloroquine (HCQ) does not reduce the risk for infection in people exposed to patients with confirmed COVID-19, according to data from a randomized, double-blind, placebo-controlled prevention trial. The trial enrolled 821 asymptomatic part...

COVID-19 Update: NEJM, Lancet Studies Retracted; A Look at One Key Author
https://www.medscape.com/viewarticle/931800

Jun 3rd, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Here are the coronavirus stories Medscape's editors around the globe think you need to know about today:  Two Journal Studies Retracted Authors of a hydroxychloroquine (HCQ) analysis published in The Lancet and a cardiovascular disease study in th...

HCQ Fails to Prevent COVID-19 in Randomized Trial
https://emedicine.medscape.com/viewarticle/931703

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Hydroxychloroquine (HCQ) does not reduce the risk for infection in people exposed to patients with confirmed COVID-19, according to data from a randomized, double-blind, placebo-controlled prevention trial. The trial enrolled 821 asymptomatic part...

COVID-19 Update: NEJM, Lancet Studies Retracted; A Look at One Key Author
https://emedicine.medscape.com/viewarticle/931800

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Here are the coronavirus stories Medscape's editors around the globe think you need to know about today:  Two Journal Studies Retracted Authors of a hydroxychloroquine (HCQ) analysis published in The Lancet and a cardiovascular disease study in th...

Two Journals Retract Studies on HCQ, Heart Disease in COVID-19
https://emedicine.medscape.com/viewarticle/931774

Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. The Lancet announced today that it has retracted a highly cited study that suggested hydroxychloroquine may cause more harm than benefit in patients with COVID-19. Hours later, the New England Journal of Medicine announced th...

Understanding the Puzzling Pathology of COVID-19
https://emedicine.medscape.com/viewarticle/931591

Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. This transcript has been edited for clarity. Andrew N. Wilner, MD: Welcome to Medscape. I'm Dr Andrew Wilner, and today I have the pleasure of speaking with Dr William Li, president and medical director of the Angiogenesis Foundation. Welcome, Dr Li. William W. Li, MD: Thank ...

New Global Registry Investigates COVID-19 and New-Onset Diabetes
https://www.medscape.com/viewarticle/932282

Jun 12th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. A new global registry has been established to collect data on patients with COVID-19-related diabetes. Emerging evidence suggests that COVID-19 may actually trigger the onset of diabetes in healthy people. A notice about the CoviDiab...

Preventing Arrhythmias and QTc Prolongation in COVID-19 Patients on Psychotropics
https://emedicine.medscape.com/viewarticle/932615

Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Over the last few weeks, several conflicting reports about the efficacy of SARS-CoV-2 treatments have emerged, including high-profile papers that were placed in the limelight and groundbreaking retractions that were issued by the Lancet and New England ...

Preventing Arrhythmias and QTc Prolongation in COVID-19 Patients on Psychotropics
https://www.medscape.com/viewarticle/932615

Jun 17th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Over the last few weeks, several conflicting reports about the efficacy of SARS-CoV-2 treatments have emerged, including high-profile papers that were placed in the limelight and groundbreaking retractions that were issued by the Lancet and New England ...

No Shame in Choosing Not to Be a COVID-19 Hero
https://www.medscape.com/viewarticle/932918

Jun 24th, 2020 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. This transcript has been edited for clarity. Michelle L. O'Donoghue, MD, MPH: Hi. This is Dr Michelle O'Donoghue, reporting for Medscape. Joining me today is Dr Lisa Rosenbaum. She is a cardiologist with me at Brigham and Women's Hospital, and she is also a medical writer for...